SCHEMBL9867451

SCHEMBL9867451

CCOc1ccc(-c2nsc(SN)n2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.49
MAPT P10636 6/20 0.49
TP53 P04637 4/20 0.49
HSD17B10 Q99714 4/20 0.49
HPGD P15428 2/20 0.49
ALOX15 P16050 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.43
KDM4E B2RXH2 6/20 0.42
RAB9A P51151 6/20 0.42
SMN1; SMN2 Q16637 6/20 0.42
NPC1 O15118 5/20 0.42
GAA P10253 2/20 0.42
XDH P47989 1/20 0.42
MPI P34949 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
NQO1 P15559 1/20 0.41
TDP1 Q9NUW8 2/20 0.40
TSHR P16473 1/20 0.40
ADORA3 P0DMS8 1/20 0.39
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9867822 0.83 MAPT (0.55) ALDH1A1MAPTTP53HSD17B10HPGD
SCHEMBL9877197 0.78 ALDH1A1 (0.45) ALDH1A1MAPTTP53HSD17B10HPGD
SCHEMBL9866517 0.75 CA2 (0.51) ALDH1A1MAPTTP53HSD17B10HPGD
SCHEMBL9866657 0.74 NPC1 (0.46) ALDH1A1MAPTTP53HSD17B10HPGD
SCHEMBL9866528 0.74 CYP19A1 (0.41) ALDH1A1MAPTTP53HSD17B10HPGD
SCHEMBL9867210 0.74 ADORA3 (0.58) ALDH1A1TP53L3MBTL1RAB9ASMN1; SMN2
SCHEMBL9875069 0.74 CYP19A1 (0.41) ALDH1A1MAPTTP53HSD17B10HPGD
SCHEMBL21887689 0.73 NQO1 (0.64) ALDH1A1MAPTTP53HSD17B10HPGD
SCHEMBL24217511 0.72 ALDH1A1 (0.67) ALDH1A1MAPTTP53HSD17B10HPGD
SCHEMBL9868361 0.71 MKNK1 (0.41) KDM4ERAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4985450-A TREATMENT OF GLAUCOMA AVENTIS PHARMACEUTICALS INC. 1991-01-15 US claimed